CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Astellas Pharma Inc. - 4503 CFD

1512.58
0.29%
Market Trading Hours* (UTC) Opens on Thursday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:25

  • Summary
  • Historical Data
Trading сonditions
Spread 3.84
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.011658 %
Charges from full value of position ($-2.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011658%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010565 %
Charges from full value of position ($-2.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010565%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 1514.18
Open 1508.78
1-Year Change -6.22%
Day's Range 1502.79 - 1514.08
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 18, 2024 1504.99 -6.09 -0.40% 1511.08 1514.18 1502.79
Dec 17, 2024 1514.18 1.40 0.09% 1512.78 1522.07 1502.79
Dec 16, 2024 1523.07 -29.47 -1.90% 1552.54 1553.94 1517.67
Dec 13, 2024 1552.04 -0.50 -0.03% 1552.54 1567.02 1542.65
Dec 12, 2024 1574.12 -1.90 -0.12% 1576.02 1587.10 1570.62
Dec 11, 2024 1573.92 -5.09 -0.32% 1579.01 1589.00 1566.62
Dec 10, 2024 1577.52 -13.58 -0.85% 1591.10 1594.00 1570.62
Dec 9, 2024 1579.41 -0.20 -0.01% 1579.61 1590.50 1572.12
Dec 6, 2024 1575.92 -7.69 -0.49% 1583.61 1592.30 1571.62
Dec 5, 2024 1588.50 -14.49 -0.90% 1602.99 1605.09 1583.61
Dec 4, 2024 1599.59 -2.00 -0.12% 1601.59 1604.99 1590.60
Dec 3, 2024 1612.58 14.49 0.91% 1598.09 1622.47 1591.60
Dec 2, 2024 1583.41 20.28 1.30% 1563.13 1587.11 1560.13
Nov 29, 2024 1560.43 2.30 0.15% 1558.13 1567.83 1546.15
Nov 28, 2024 1566.03 -2.59 -0.17% 1568.62 1570.72 1553.44
Nov 27, 2024 1564.13 -6.89 -0.44% 1571.02 1571.72 1557.63
Nov 26, 2024 1566.43 -2.69 -0.17% 1569.12 1569.12 1548.64
Nov 25, 2024 1567.62 -21.98 -1.38% 1589.60 1599.49 1566.13
Nov 22, 2024 1563.93 -5.69 -0.36% 1569.62 1574.02 1555.14
Nov 21, 2024 1569.72 -11.49 -0.73% 1581.21 1596.90 1566.12

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Astellas Pharma Inc. Company profile

About Astellas Pharma Inc

Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Astellas Pharma Inc revenues increased 5% to Y992.29B. Net income applicable to common stockholders decreased less than 1% to Y132.49B. Revenues reflect Sales of Pharmaceuticals segment increase of 6% to Y971.11B, Other Business segment increase of 33% to Y14.07B, Americas segment increase of 15% to Y407.94B, Estabridge segment increase of 10% to Y239.22B.

Equity composition

04/2005, Company merged with Fujisawa Pharmaceutical Co., Ltd. & Name Changed from Yamanouchi Pharmaceutical Co., Ltd. FY'08 1Q&Q3 WAS & DWAS estimated and WAS used as O/S. FY'09 Q3,12 Q2 DWAS estimated.

Industry: Pharmaceuticals (NEC)

日本橋本町2-5-1
CHUO-KU
TOKYO-TO 103-8411
JP

People also watch

US100

21,148.50 Price
-3.790% 1D Chg, %
Long position overnight fee -0.0243%
Short position overnight fee 0.0020%
Overnight fee time 22:00 (UTC)
Spread 7.0

XRP/USD

2.34 Price
-10.470% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01167

BTC/USD

100,647.15 Price
-5.400% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,585.90 Price
-2.330% 1D Chg, %
Long position overnight fee -0.0083%
Short position overnight fee 0.0001%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading